KK
SRPT icon

KLP Kapitalforvaltning’s Sarepta Therapeutics SRPT Stock Holding History

KLP Kapitalforvaltning’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Hold
21,300
– – ﹤0.01% 1629
2026
Q1 		$463K Hold
21,300
– – ﹤0.01% 1458
2025
Q4 		$458K Buy
21,300
+3,500
+20% +$73.8K ﹤0.01% 1459
2025
Q3 		$343K Hold
17,800
– – ﹤0.01% 1595
2025
Q2 		$304K Hold
17,800
– – ﹤0.01% 1598
2025
Q1 		$1.14M Hold
17,800
– – 0.01% 872
2024
Q4 		$2.16M Buy
+17,800
New +$2.18M 0.01% 641

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KLP Kapitalforvaltning's SRPT Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 21,300 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #1629.

KLP Kapitalforvaltning first reported a position in SRPT in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.16M in Q4 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • KLP Kapitalforvaltning held 21,300 shares of Sarepta Therapeutics worth $383K as of Q2 2026.
  • KLP Kapitalforvaltning left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1629 holding.
  • KLP Kapitalforvaltning first reported a position in Sarepta Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Sarepta Therapeutics position peaked at $2.16M in Q4 2024.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.